Avoro Life Sciences Fund LLC of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2016-10-11. $412.9M was reported sold. Industry: Pooled Investment Fund.
| Name | Role | Location |
|---|---|---|
| Robert Adelman | Executive Officer | San Francisco, CA |
| Corey Goodman | Executive Officer | Cambridge, MA |
| LLC venBio Select Advisor | Promoter | San Francisco, CA |
| Kurt von Emster | Executive Officer | Redwood City, CA |
| Kurt von Emster | Promoter | Redwood City, CA |
| Behzad Aghazadeh | Executive Officer | New York, NY |
| Behzad Aghazadeh | Related Person | New York, NY |
| Scott Epstein | Executive Officer | New York, NY |
| Scott Epstein | Related Person | New York, NY |
| - Avoro Capital L.P. | Promoter | New York, NY |
| - Avoro Capital GP, LLC | Promoter | New York, NY |
| - Avoro Capital Advisors LLC | Promoter | New York, NY |
| Neil Cammarosano | Executive Officer | New York, NY |
| Neil Cammarosano | Related Person | New York, NY |
| N/A venBio Select Advisor LLC | Promoter | New York, NY |
| N/A venBio Select Advisor Management Holdings GP, LLC | Promoter | New York, NY |
| N/A venBio Select Advisor L.P. | Promoter | New York, NY |
| Paul Brooke | Executive Officer | San Francisco, CA |
Showing 15 of 16 filings.
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2026-05-01 | D/A | — | $3.5B |
| 2025-05-02 | D/A | — | $3.3B |
| 2024-05-02 | D/A | — | $3.2B |
| 2023-05-02 | D/A | — | $2.8B |
| 2022-05-02 | D/A | — | $2.5B |
| 2021-05-03 | D/A | — | $2.0B |
| 2020-05-06 | D/A | — | $1.7B |
| 2019-05-22 | D/A | — | $1.3B |
| 2018-09-07 | D/A | — | $1.2B |
| 2017-10-11 | D/A | — | $629.9M |
| 2015-10-09 | D/A | — | $292.6M |
| 2014-10-17 | D/A | — | $124.0M |
| 2013-10-21 | D/A | — | $37.6M |
| 2012-10-18 | D/A | — | $21.8M |
| 2011-08-01 | D/A | — | $15.5M |